Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 04, 2024
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
Journal: Emerging infectious diseases
Published: January 25, 2024
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials.
Journal: The Lancet. Infectious diseases
Published: August 31, 2022
Showing 1-4 of 4
Last Updated: 09/26/2026